Shui, C <br/><br/>
The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.  [electronic resource] 

 -  Calcified tissue international  Nov 2002 
 - 437-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0171-967X 
<br/><br/><label>Standard No.: </label>10.1007/s00223-001-1138-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--genetics<br/>Animals<br/>Carrier Proteins--pharmacology<br/>Cell Differentiation--drug effects<br/>Cell Division<br/>Cell Line<br/>Cyclosporine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Drug Synergism<br/>Immunosuppressive Agents--pharmacology<br/>Isoenzymes--genetics<br/>Membrane Glycoproteins--pharmacology<br/>Mice<br/>Monocytes--drug effects<br/>Osteoclasts--drug effects<br/>RANK Ligand<br/>RNA, Messenger--metabolism<br/>Receptor Activator of Nuclear Factor-kappa B<br/>Receptors, Calcitonin--genetics<br/>Sirolimus--pharmacology<br/>Tacrolimus--pharmacology<br/>Tartrate-Resistant Acid Phosphatase<br/>Transforming Growth Factor beta--pharmacology